Bel20 (BEL20.BXS)

Close: 4 072.15 (+5.66), May 17, 2021
Positive

Medium risk

Automatic technical analysis. Medium term, May 17, 2021

Investors have paid higher prices over time to buy Bel20 and the index is in a rising trend channel in the medium long term. This signals increasing optimism among investors and indicates continued rise. The price has risen strongly since the positive signal from rectangle formation at the break through the resistance at 3782. The objective at 3964 is now met, but the formation still gives a signal in the same direction. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 3760 points. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive (Score: 93)

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.13%0.00+0.14%
5 days0.003.87%0.00+0.68%
22 days0.0010.74%0.00+3.32%
66 days0.0025.38%0.00+6.58%

More analyses of Bel20

chart Bel20 (BEL20) Candlesticks 22 Days
Candlesticks
chart Bel20 (BEL20) Short term
Short term: Positive
chart Bel20 (BEL20) Medium term
Medium term: Positive
chart Bel20 (BEL20) Long term
Long term: Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK